Sorting out the key points of the second batch of national volume procurement (with colored eggs)

On the afternoon of December 29, the national centralized drug purchase document was officially issued The author briefly combed and analyzed the key points of the second batch of national volume purchase as follows: 1 Application varieties There are 33 varieties and 50 specifications declared this time The 33 varieties, tadalafei tablets, paclitaxel for injection (albumin binding type), and alisentan are not the new version of the national medical insurance catalogue (2019 version of the medical insurance catalogue), but are included in the scope of national volume procurement, which means that the trend of national joint procurement has shifted from medical insurance control to patients' needs Pay close attention 2、 The relationship between the number of selected companies and the calculation base of the agreed procurement volume in the first year, the procurement cycle 3, the key points of the selection flow chart 4, the specific analysis of the selection flow 1, the quotation is the same as 4 + 7, the joint mining expansion, and still belongs to the one price fixed Jiangshan 2 The three requirements of quotation should bear in mind that in fact, the so-called shortlist of volume purchase is only the second pass of "qualification" acquisition The first pass is the so-called effective bid Some enterprises that want to pass the first pass have nearly half their lives left The shortlisted enterprises of the second pass are not safe, but pass the second pass In fact, the third pass that you understand should be combined with the second pass, rather than passing the second pass to see whether it meets the conditions for the proposed winner Because the number of shortlisted enterprises policy is very clear, "the maximum number of shortlisted enterprises", in other words, the maximum is not necessarily the maximum, but also may be the minimum If the enterprise quotation strategy is appropriate, shortlisted is to some extent the winning bid If there is a problem with the offer, the shortlist is just the shortlist In fact, when enterprises quote, they will fully consider how to effectively open the gap between them and meet the requirements of the third level on the basis of price limit declaration Through the 4 + 7 centralized procurement policy, the expansion of joint procurement and the official issuance of centralized procurement documents by the state, it is actually an adjustment from the pilot to the comprehensive promotion, from the only low price to the adjustment that encourages the market to fully compete and avoid price bargaining The logic behind it is to ensure a certain profit as the premise, so that the selected enterprises can share the market together and ensure stable supply From the perspective of drug recruitment organizations, they also do not want to have too much reduction, and the price is too low, which will inevitably damage the healthy development of the market, and is not conducive to the innovation and sustainability of the pharmaceutical market If you want to get the PDF version of the original process, please pay attention to WeChat official account (yaozh008), leave a message and attach a mailbox, and will be sent to you by staff within three working days Listen to white